A detailed history of Private Capital Group, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Private Capital Group, LLC holds 34 shares of BNTX stock, worth $3,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 62 45.16%
Holding current value
$3,844
Previous $11,000 54.55%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$123.25 - $186.24 $3,451 - $5,214
-28 Reduced 45.16%
34 $5,000
Q1 2022

Apr 21, 2022

BUY
$126.25 - $231.85 $2,398 - $4,405
19 Added 44.19%
62 $11,000
Q4 2021

Jan 24, 2022

BUY
$216.64 - $362.52 $9,315 - $15,588
43 New
43 $11,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.